Skip to main content

Table 2 Demographic data of study participants

From: Patterns of use and appropriateness of antibiotics prescribed to patients receiving haemodialysis: an observational study

Variable

Community (n = 81)

Hospital (n = 33)

Total (n = 114)

p-values

Age, median (IQR)

65 (51.5–77.5)

64 (50–74)

64 (50.8–75)

0.334

Baseline dry weight (kg), median (IQR)

71.0 (60.5–85.5)

72.0 (61.0–92.3)

72.0 (60.9–87.1)

0.413

Male (%)

46 (56.8)

20 (60.6)

68 (59.7)

0.894

Ethnicity (%)

0.039*

 Caucasian

55 (67.9)

30 (90.9)

85 (74.6)

 Asian

13 (16.1)

1 (3.0)

14 (12.3)

 Other

13 (16.1)

2 (6.1)

15 (13.2)

Primary indication of ESRD requiring HD (%)

0.922

 Diabetes

34 (42.0)

12 (36.4)

46 (40.4)

 Glomerulonephritis

13 (16.1)

6 (18.2)

19 (16.7)

 Hypertension

7 (8.6)

2 (6.1)

9 (7.9)

 Polycystic kidney disease

4 (4.9)

2 (6.1)

6 (5.3)

 Other

18 (22.2)

10 (30.3)

28 (24.6)

 Unknown

5 (6.2)

1 (3.0)

6 (5.3)

Vascular access type at enrollment (%)

0.018*

 AV fistula

62 (76.5)

19 (57.6)

81 (71.1)

 AV graft

10 (12.4)

3 (9.1)

13 (11.4)

 Catheter

9 (11.1)

11 (33.3)

20 (17.5)

Years receiving HD at enrollment, median (IQR)

3.17 (1.1–5.9)

1.5 (0.4–3.5)

2.4 (0.9–5.5)

0.005*

Current smokers (%)

11 (13.6)

4 (12.1)

15 (13.2)

1.000

Comorbidities

 Diabetes

43 (53.1)

12 (36.4)

55 (48.2)

0.105

 Cardiovascular disease

78 (96.3)

30 (90.1)

108 (94.7)

0.354

 Dyslipidaemia

32 (39.5)

15 (45.5)

47 (41.2)

0.558

 Respiratory disease

10 (12.3)

11 (33.3)

21 (18.4)

0.009*

 Previous or current diagnosis of cancer

14 (17.3)

8 (24.2)

22 (19.3)

0.393

Allergy to antibiotics (%)

1.000

Allergy to one antibiotic only:

 Pencillins

5 (6.2)

2 (6.1)

7 (6.1)

 Cephalosporins

2 (2.5)

1 (3.0)

3 (2.6)

 Other antibiotics

2 (2.5)

1 (3.0)

3 (2.6)

 Allergies to two or more antibiotics

6 (7.4)

2 (6.1)

8 (7.0)

Previous kidney transplant (%)

11 (13.6)

9 (27.3)

20 (17.5%)

0.081

Anuric (%)

46 (56.8)

16 (48.5)

62 (54.4)

0.298

  1. AV arteriovenous, ESRD end stage renal disease, HD haemodialysis, IQR interquartile range
  2. *p-value <0.05